Quest Diagnostics Pre-Tax Income 2010-2024 | DGX

Quest Diagnostics annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Quest Diagnostics pre-tax income for the quarter ending September 30, 2024 was $0.296B, a 1% decline year-over-year.
  • Quest Diagnostics pre-tax income for the twelve months ending September 30, 2024 was $1.113B, a 11.08% increase year-over-year.
  • Quest Diagnostics annual pre-tax income for 2023 was $1.13B, a 8.5% decline from 2022.
  • Quest Diagnostics annual pre-tax income for 2022 was $1.235B, a 52.48% decline from 2021.
  • Quest Diagnostics annual pre-tax income for 2021 was $2.599B, a 37.95% increase from 2020.
Quest Diagnostics Annual Pre-Tax Income
(Millions of US $)
2023 $1,130
2022 $1,235
2021 $2,599
2020 $1,884
2019 $1,076
2018 $926
2017 $1,030
2016 $1,086
2015 $1,103
2014 $823
2013 $1,324
2012 $1,068
2011 $849
2010 $1,175
2009 $1,228
Quest Diagnostics Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $296
2024-06-30 $314
2024-03-31 $266
2023-12-31 $237
2023-09-30 $299
2023-06-30 $317
2023-03-31 $277
2022-12-31 $109
2022-09-30 $351
2022-06-30 $323
2022-03-31 $452
2021-12-31 $502
2021-09-30 $654
2021-06-30 $817
2021-03-31 $626
2020-12-31 $758
2020-09-30 $753
2020-06-30 $255
2020-03-31 $118
2019-12-31 $328
2019-09-30 $270
2019-06-30 $265
2019-03-31 $213
2018-12-31 $167
2018-09-30 $266
2018-06-30 $264
2018-03-31 $229
2017-12-31 $234
2017-09-30 $258
2017-06-30 $292
2017-03-31 $246
2016-12-31 $242
2016-09-30 $289
2016-06-30 $383
2016-03-31 $172
2015-12-31 $206
2015-09-30 $592
2015-06-30 $200
2015-03-31 $105
2014-12-31 $204
2014-09-30 $214
2014-06-30 $229
2014-03-31 $176
2013-12-31 $214
2013-09-30 $657
2013-06-30 $256
2013-03-31 $197
2012-12-31 $231
2012-09-30 $271
2012-06-30 $298
2012-03-31 $268
2011-12-31 $285
2011-09-30 $283
2011-06-30 $278
2011-03-31 $3
2010-12-31 $258
2010-09-30 $311
2010-06-30 $330
2010-03-31 $277
2009-12-31 $292
2009-09-30 $326
2009-06-30 $322
2009-03-31 $288
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.912B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00